![Jessica Oien](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jessica Oien
Consigliere Generale presso BOUNDLESS BIO, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Jessica Oien
Società | Posizione | Inizio | Fine |
---|---|---|---|
BOUNDLESS BIO, INC. | Consigliere Generale | 01/08/2021 | - |
Segretario Aziendale | 01/08/2021 | - |
Storia della carriera di Jessica Oien
Precedenti posizioni note di Jessica Oien
Società | Posizione | Inizio | Fine |
---|---|---|---|
CIDARA THERAPEUTICS, INC. | Consigliere Generale | 01/09/2018 | 01/09/2021 |
Segretario Aziendale | 03/12/2018 | 01/09/2021 | |
OTONOMY | Responsabile della Conformità | 01/01/2015 | 01/01/2018 |
Verus Pharmaceuticals, Inc.
![]() Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verus Pharmaceuticals, Inc. was provided pediatric-oriented pharmaceutical products. The company was founded by David A. Socks, James Carroll Blair, Robert W. Keith, Cam L. Garner and David F. Hale in 2002 and was headquartered in San Diego, CA. | Consigliere Generale | 01/01/2007 | 01/01/2008 |
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Consigliere Generale | 01/01/2001 | 01/01/2007 |
Brobeck, Phleger & Harrison LLP | Consigliere Generale | - | - |
Somaxon Pharmaceuticals, Inc.
![]() Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Responsabile della Conformità | 01/01/2011 | - |
Consigliere Generale | 01/01/2011 | - | |
PERNIX THERAPEUTICS HOLDINGS INC | Responsabile della Conformità | 04/03/2014 | - |
Corporate Officer/Principal | 04/03/2014 | - |
Formazione di Jessica Oien
Loyola Law School | Graduate Degree |
North Dakota State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Posizioni
General Counsel | 6 |
Compliance Officer | 3 |
Corporate Secretary | 2 |
Settori
Health Technology | 8 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
CIDARA THERAPEUTICS, INC. | Health Technology |
BOUNDLESS BIO, INC. | Health Technology |
Aziende private | 6 |
---|---|
Pernix Therapeutics Holdings, Inc.
![]() Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
Otonomy, Inc.
![]() Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
Somaxon Pharmaceuticals, Inc.
![]() Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company focuses on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Its product, Silenor, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. Somaxon Pharmaceuticals was founded in August 2003 and is headquartered in Solana Beach, CA. | Health Technology |
Verus Pharmaceuticals, Inc.
![]() Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verus Pharmaceuticals, Inc. was provided pediatric-oriented pharmaceutical products. The company was founded by David A. Socks, James Carroll Blair, Robert W. Keith, Cam L. Garner and David F. Hale in 2002 and was headquartered in San Diego, CA. | Health Technology |
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Brobeck, Phleger & Harrison LLP | Commercial Services |
- Borsa valori
- Insiders
- Jessica Oien
- Esperienza